Jinhe Biotechnology Co Ltd (002688) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.088x

Based on the latest financial reports, Jinhe Biotechnology Co Ltd (002688) has a cash flow conversion efficiency ratio of 0.088x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥229.93 Million ≈ $33.65 Million USD) by net assets (CN¥2.60 Billion ≈ $380.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002688 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Jinhe Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Jinhe Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jinhe Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jinhe Biotechnology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Heilongjiang Transport Development Co Ltd SHG:601188	0.024x
Phreesia Inc NYSE:PHR	0.048x
Zheshang Development Group Co Ltd SHE:000906	-0.164x
Grupa Azoty S.A. WAR:ATT	0.476x
SSAW Hotels & Resorts Group Co.Ltd. SHE:301073	N/A
Flying Technology Co Ltd SHG:603488	0.041x
Klaveness Combination Carriers ASA OL:KCC	0.058x
Jamna Auto Industries Limited NSE:JAMNAAUTO	0.273x

Annual Cash Flow Conversion Efficiency for Jinhe Biotechnology Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Jinhe Biotechnology Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 002688 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.50 Billion ≈ $365.81 Million	CN¥498.42 Million ≈ $72.94 Million	0.199x	+152.45%
2023-12-31	CN¥2.52 Billion ≈ $368.27 Million	CN¥198.77 Million ≈ $29.09 Million	0.079x	+53.88%
2022-12-31	CN¥2.43 Billion ≈ $354.89 Million	CN¥124.47 Million ≈ $18.21 Million	0.051x	-9.53%
2021-12-31	CN¥2.70 Billion ≈ $394.58 Million	CN¥152.98 Million ≈ $22.39 Million	0.057x	-61.53%
2020-12-31	CN¥1.75 Billion ≈ $256.07 Million	CN¥258.08 Million ≈ $37.77 Million	0.147x	-5.57%
2019-12-31	CN¥1.81 Billion ≈ $264.40 Million	CN¥282.19 Million ≈ $41.29 Million	0.156x	+137.16%
2018-12-31	CN¥1.78 Billion ≈ $260.38 Million	CN¥117.17 Million ≈ $17.15 Million	0.066x	+295.62%
2017-12-31	CN¥1.64 Billion ≈ $239.59 Million	CN¥27.25 Million ≈ $3.99 Million	0.017x	-90.98%
2016-12-31	CN¥1.58 Billion ≈ $231.81 Million	CN¥292.41 Million ≈ $42.79 Million	0.185x	-9.45%
2015-12-31	CN¥1.05 Billion ≈ $154.31 Million	CN¥214.97 Million ≈ $31.46 Million	0.204x	+435.95%
2014-12-31	CN¥956.13 Million ≈ $139.91 Million	CN¥-58.02 Million ≈ $-8.49 Million	-0.061x	-136.82%
2013-12-31	CN¥900.07 Million ≈ $131.71 Million	CN¥148.32 Million ≈ $21.70 Million	0.165x	+60.24%
2012-12-31	CN¥863.55 Million ≈ $126.36 Million	CN¥88.81 Million ≈ $13.00 Million	0.103x	-67.74%
2011-12-31	CN¥334.40 Million ≈ $48.93 Million	CN¥106.59 Million ≈ $15.60 Million	0.319x	-31.19%
2010-12-31	CN¥254.83 Million ≈ $37.29 Million	CN¥118.05 Million ≈ $17.27 Million	0.463x	+291.50%
2009-12-31	CN¥196.03 Million ≈ $28.69 Million	CN¥23.20 Million ≈ $3.39 Million	0.118x	+80.81%
2008-12-31	CN¥177.82 Million ≈ $26.02 Million	CN¥11.64 Million ≈ $1.70 Million	0.065x	--

About Jinhe Biotechnology Co Ltd

SHE:002688 China Drug Manufacturers - Specialty & Generic

Market Cap

$563.44 Million

CN¥3.85 Billion CNY

Market Cap Rank

#11805 Global

#3416 in China

Share Price

CN¥4.99

Change (1 day)

-1.19%

52-Week Range

CN¥4.88 - CN¥7.91

All Time High

CN¥10.94